Oscar Health, Inc.
OSCR
$18.02
-$0.07-0.39%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | 1.45B | 1.43B | 1.52B | 1.47B | 997.83M |
Total Other Revenue | -19.27M | 11.40M | 3.86M | 3.89M | 8.05M |
Total Revenue | 1.43B | 1.44B | 1.52B | 1.47B | 1.01B |
Cost of Revenue | 1.21B | 1.16B | 1.18B | 1.09B | 884.90M |
Gross Profit | 220.82M | 280.00M | 340.36M | 378.11M | 120.98M |
SG&A Expenses | 225.68M | 158.19M | 163.74M | 176.04M | 160.64M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 140.62M | 180.05M | 183.15M | 227.43M | 182.82M |
Total Operating Expenses | 1.57B | 1.50B | 1.53B | 1.50B | 1.23B |
Operating Income | -145.48M | -58.24M | -6.53M | -25.37M | -222.48M |
Income Before Tax | -150.64M | -64.79M | -14.26M | -37.61M | -227.28M |
Income Tax Expenses | -806.00K | 915.00K | 1.16M | 2.02M | -715.00K |
Earnings from Continuing Operations | -149.84M | -65.70M | -15.43M | -39.63M | -226.56M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -192.00K | 305.00K | -103.00K | -144.00K | 514.00K |
Net Income | -150.03M | -65.40M | -15.53M | -39.77M | -226.05M |
EBIT | -145.48M | -58.24M | -6.53M | -25.37M | -222.48M |
EBITDA | -137.74M | -49.05M | 2.29M | -20.43M | -218.74M |
EPS Basic | -0.66 | -0.29 | -0.07 | -0.18 | -1.05 |
Normalized Basic EPS | -0.42 | -0.18 | -0.04 | -0.11 | -0.66 |
EPS Diluted | -0.66 | -0.29 | -0.07 | -0.18 | -1.05 |
Normalized Diluted EPS | -0.42 | -0.18 | -0.04 | -0.11 | -0.66 |
Average Basic Shares Outstanding | 227.08M | 223.10M | 219.40M | 216.91M | 215.19M |
Average Diluted Shares Outstanding | 227.08M | 223.10M | 219.40M | 216.91M | 215.19M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |